Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Journal Article
Anastasilakis, D. A., Makras P., Polyzos S. A., & Anastasilakis A. D. (2019).  Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview.. Hormones (Athens). 18(1), 65-70.
Nicolaides, A. N., Kakkos S. K., Kyriacou E., Griffin M., Sabetai M., Thomas D. J., et al. (2010).  Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification.. J Vasc Surg. 52(6), 1486-1496.e1-5.
Grammatikopoulou, M. G., Lampropoulou M. Α., Milapidou M., & Goulis D. G. (2021).  At the heart of the matter: Cardiovascular health challenges among incarcerated women.. Maturitas. 149, 16-25.
Karagiannis, A., Mikhailidis D. P., Kakafika A. I., Tziomalos K., & Athyros V. G. (2007).  Atenolol: differences in mode of action compared with other antihypertensives. An opportunity to identify features that influence outcome?. Curr Pharm Des. 13(2), 229-39.
Anagnostis, P., Karagiannis A., Kakafika A. I., Tziomalos K., Athyros V. G., & Mikhailidis D. P. (2009).  Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?. Osteoporos Int. 20(2), 197-207.
Stavrinou, E., Koumaras C., Gossios T. D., Tziomalos K., Athyros V. G., & Karagiannis A. (2011).  Atherosclerotic renal artery stenosis: an update on diagnosis and management.. Curr Vasc Pharmacol. 9(4), 465-70.
Karagiannis, A., Tziomalos K., Anagnostis P., Gossios T., & Athyros V. G. (2009).  Atherosclerotic renal artery stenosis: medical therapy alone or in combination with revascularization?. Angiology. 60(4), 397-402.
Pagourelias, E. D., Efthimiadis G. K., Kouidi E., Fragakis N., Athyros V. G., & Geleris P. (2011).  Athlete's heart or hypertrophic cardiomyopathy: the dilemma is still there.. Am J Cardiol. 108(12), 1841-2.
Natsis, K., Piperaki E-T., Fratzoglou M., Lazaridis N., Tsitsopoulos P. P., Samolis Α., et al. (2019).  Atlas posterior arch and vertebral artery's groove variants: a classification, morphometric study, clinical and surgical implications.. Surg Radiol Anat. 41(9), 985-1001.
Tsitlakidis, A., Tsingotjidou A. S., Kritis A., Cheva A., Selviaridis P., Aifantis E. C., et al. (2021).  Atomic Force Microscope Nanoindentation Analysis of Diffuse Astrocytic Tumor Elasticity: Relation with Tumor Histopathology.. Cancers (Basel). 13(18), 
Strafella, C., Caputo V., Minozzi G., Milano F., Arcangeli M., Sobhy N., et al. (2019).  Atopic Eczema: Genetic Analysis of , , and in Mediterranean Populations.. Biomed Res Int. 2019, 3457898.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Tziomalos K., Skaperdas A., Pagourelias E., et al. (2007).  Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients.. Lipids. 42(11), 999-1009.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Atorvastatin: safety and tolerability.. Expert Opin Drug Saf. 9(4), 667-74.
Heerspink, H. J. L., Parving H-H., Andress D. L., Bakris G., Correa-Rotter R., Hou F-F., et al. (2019).  Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.. Lancet. 393(10184), 1937-1947.
Koutsampasopoulos, K., Datsios A., Grigoriadis S., & Vogiatzis I. (2016).  Atrial fibrillation causing ST elevation myocardial infarction due to coronary embolism: case report and review of the literature.. Hippokratia. 20(2), 160-162.
Tailachidis, P., Tsimtsiou Z., Galanis P., Theodorou M., Kouvelas D., & Athanasakis K. (2016).  The Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) questionnaire: cultural adaptation and validation of the Greek version.. Hippokratia. 20(4), 264-267.
Zegkos, T., Efthimiadis G. K., Parcharidou D. G., Gossios T. D., Giannakoulas G., Ntelios D., et al. (2017).  Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.. Hellenic J Cardiol. 58(5), 331-339.
Kallaras, K., Babas G., Stergiou-Michailidou V., Karamouzis M., & Zaraboukas T. (2009).  Atrial natriuretic peptide decreases aorta stiffness in cholesterol-fed anesthetized rabbits.. Pharmacol Res. 60(4), 324-31.
Giannopoulos, A., Gavras C., Sarioglou S., Agathagelou F., Kassapoglou I., & Athanassiadou F. (2014).  Atrial septal aneurysms in childhood: prevalence, classification, and concurrent abnormalities.. Cardiol Young. 24(3), 453-8.
Giannakoulas, G., Savvoulidis P., Grosomanidis V., Mouratoglou S-A., Karvounis H., & Hadjimiltiades S. (2016).  Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis.. BMC Pulm Med. 16(1), 175.
Giakoustidis, D. E., Giakoustidis A. E., Iliadis S., Koliakou K., Antoniadis N., Kontos N., et al. (2010).  Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression.. J Surg Res. 159(2), 720-8.
Korhonen, R., Turpeinen T., Taimi V., Nieminen R., Goulas A., & Moilanen E. (2011).  Attenuation of the acute inflammatory response by dual specificity phosphatase 1 by inhibition of p38 MAP kinase.. Mol Immunol. 48(15-16), 2059-68.
Jung, M., Hoerbst A., Hackl W. O., Kirrane F., Borbolla D., Jaspers M. W., et al. (2013).  Attitude of physicians towards automatic alerting in computerized physician order entry systems. A comparative international survey.. Methods Inf Med. 52(2), 99-108.
Tsolaki, M., Paraskevi S., Degleris N., & Karamavrou S. (2009).  Attitudes and perceptions regarding Alzheimer's disease in Greece.. Am J Alzheimers Dis Other Demen. 24(1), 21-6.
Papaioannidou, P., Tsanakalis F., & Akritopoulos A. (2009).  Attitudes in Antibiotic Use by General Population in Greece. Pharmacoepidemiol Drug Safety. 18(S), 145.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.